Winners and losers: Will big firms benefit from the Covid-19 crunch?

ANALYSIS: As the prospect of a widely distributed vaccine draws nearer – AstraZeneca and Oxford University announced results for their jab last week, bosses and investors are turning one eye away from the immediate struggle of coping with the pandemic and looking instead at the longer-term competitive picture. Who has won and who has lost?

Like viruses, recessions usually come for the weakest first. Companies with sickly balance-sheets or frail margins quickly succumb. As promising startups become crushed closedowns, it is often the incumbents that have the resources to wait it out.

Yet the Covid-19 recession has been sharper than normal, and more complicated. The world economy is expected to shrink by over 4 per cent this year, the deepest downturn since the second world war, and there is still a risk of a double-dip recession

Bail-outs, central-bank stimulus and forbearance by banks and landlords have slowed the process of

Read More

Even exercise alone has a benefit, whereas treatment alone has no impact on fatigue — ScienceDaily

Adding exercise to a genetic treatment for myotonic dystrophy type 1 (DM1) was more effective at reversing fatigue than administering the treatment alone in a study using a mouse model of the disease. In fact, exercise alone provided some benefit whereas the genetic treatment alone did not. This study, carried out by researchers at the Massachusetts General Hospital (MGH) and collaborators, has implications for patients who experience fatigue due to genetics-related musculoskeletal diseases as well as other types of illness-induced fatigue. The study appears in Molecular Therapy — Nucleic Acids.

“It’s encouraging that exercise makes a noticeable difference on its own and in combination with a genetic treatment specifically tailored for the disease,” says Thurman M. Wheeler, MD, an investigator in the department of Neurology at MGH and at Harvard Medical School. Wheeler was the senior author of the study.

DM1 is the most common muscular dystrophy in adults,

Read More

Donations benefit Salina Tech programs – News – Salina Journal

The Salina Area Technical College has received two major donations recently that came from members of the College’s Foundation Board. One donation is providing equipment for the machine tool and diesel programs, and the other is a new car for the college’s vehicle pool.

The new vehicle is a 2020 Chevy Malibu that was donated by Holm Automotive, a longtime Abilene auto dealer that recently opened a location in Salina. Dealership owner Tim Holm joined the Salina Tech Foundation board in September.

The Malibu, with a value of $20,000, is a welcome addition to the college’s vehicle pool, said college president Greg Nichols.

“We have employees traveling as much as ever — to area high schools to teach classes, visit business and industry partners, and attend recruiting events,” Nichols said. “Our vehicles are getting older, and this donation frees up $20,000 we can use instead for equipment and supplies in

Read More

No benefit seen from plasma treatment in severe COVID-19; virus may hurt male fertility

(Reuters) – The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

FILE PHOTO: Convalescent plasma samples in vials are seen before being tested for COVID-19 antibodies at the Bloodworks Northwest Laboratory during the coronavirus disease (COVID-19) outbreak in Renton, Washington, U.S. September 9, 2020. REUTERS/Lindsey Wasson

Plasma treatment shows no benefit in severe COVID-19

Blood plasma from COVID-19 survivors was of little benefit to patients with severe COVID-19 pneumonia, researchers in Argentina reported on Tuesday in The New England Journal of Medicine. So-called convalescent plasma, which delivers COVID-19 survivors’ antibodies to infected people, did not improve critically ill patients’ health status or reduce their risk of dying from the disease any better than a placebo. Researchers randomly assigned 333 hospitalized patients with severe COVID-19 pneumonia to receive convalescent

Read More

The people that benefit most when Airbnb goes public

  • Airbnb is finally going public.
  • The company’s S-1 filing did not name all of the investors who have bought shares in Airbnb over the years, as it raised more than $6 billion in funding, but it revealed who the biggest shareholders are.
  • We’ve calculated the value of their stakes based on a price of $34.88 a share.
  • Visit Business Insider’s homepage for more stories.

Airbnb has dropped the paperwork for its initial public offering, and it’s ripe with juicy details that a startup doesn’t have to disclose but a public company does, such as which investors own the largest stakes.

As is typical these days, Airbnb is using a two-tier structure where it sells Class A shares to the public, with each of those shares offering one vote per share; and it has Class B shares — which are owned only by its founders, execs and key investors — that

Read More

Princeton announces new programs to expand innovation and entrepreneurship for societal benefit at Engage 2020 conference

Princeton University’s Vice Dean for Innovation Rodney Priestley announced three new programs that aim to build a better future through research and scholarship at Engage 2020, the University’s innovation and entrepreneurship conference held Nov. 4-6.

Brad Smith gesticulates while speaking near cliffs

Microsoft President Brad Smith, a member of the Class of 1981, opened a session about the collaborative relationship of Princeton and Microsoft with review of the global nature of innovation in the 21st century.

“Innovation at Princeton is about bringing a positive impact to society,” said Priestley, who leads the Princeton Innovation initiative. “This is a bottom-up endeavor that is driven by the entire Princeton community.” A professor of chemical and biological engineering, Priestley is also an entrepreneur who has cofounded two companies based on his lab’s research.

The three new programs are:

  • Princeton Wharton Executive Education Course (for faculty):
    A partnership with the Wharton School of the University of
Read More

Effective, early interventions would benefit individual patients and healthcare system — ScienceDaily

COVID-19 treatments for people with early infection are needed urgently, according to a JAMA Viewpoint article by National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony S. Fauci, M.D., and colleagues. Treating people early in the course of infection with SARS-CoV-2, the virus that causes COVID-19, would speed their recovery, reduce the likelihood that they develop severe outcomes and reduce demand on the healthcare system, they write.

Despite experiencing only mild symptoms early in infection, many COVID-19 patients progress to severe disease that leads to hospitalization. Some also will experience lengthy recoveries and develop long-lasting fatigue, mental impairment and problems with heart and lung function.

While several treatments such as remdesivir and dexamethasone are either available or in development for severe COVID-19, interventions that can be administered early during the course of infection to prevent disease progression and longer-term complications are urgently needed.

Studies are underway to assess whether

Read More

Here’s How Elon Musk, Tesla Will Benefit From Biden Winning The White House

KEY POINTS

  • Biden’s “Build Back Better” program could help electric vehicle in the adoption
  • The clean energy policy will increase the number of charging stations across the US
  • Critical clean energy technologies may see a dramatic cost reduction

Elon Musk and Tesla may significantly benefit from a Biden administration plan to subsidize electric vehicles and roll out charging stations across the U.S.

President-elect Joe Biden revealed plans of increasing the number of electric vehicle charging stations in the country, from 27,000 to 550,000, as part of his “Build Back Better” clean energy campaign, CNBC reported.  

“Tesla would be one of the biggest winners as an electric vehicle pure play, because EVs would be very heavily subsidized under a Biden administration,” Garrett Nelson of CRFA Research said. 

“You’re looking at about a 20-fold increase in the number of EV charging stations, which would really help the electric vehicles in the adoption,” 

Read More

The need for speed and science: Virgin Hyperloop to benefit from WVU’s expertise on brain impacts

IMAGE

IMAGE: Scott Galster (right), director of applied research at the WVU Rockefeller Neurosciences Institute, shows Virgin Hyperloop CEO Jay Walder the Institute’s whole-body photobiomodulation table during a recent tour. The photons…
view more 

Credit: Greg Ellis/WVU

Before the first Virgin Hyperloop ride takes off, the brains behind pioneering neuroscience research at West Virginia University will help ensure the health and well-being of its passengers and operators.

After all, they’ll be traveling in pods through a vacuum tube – at speeds breaking 600 mph.

It sounds like science fiction. But it will be a reality grounded in science, as engineers develop and tweak the mover system that will disrupt modern transportation as we know it.

Tried-and-tested science won’t end there. Virgin Hyperloop plans to collaborate with the barrier-breaking Rockefeller Neuroscience Institute at WVU to study how traveling at excessive speeds may impact the brain and body.

The RNI, led by Dr.

Read More

China’s increasing sci-tech innovation capacity to benefit all



a group of people in a room


© Provided by N.C.N. Limited


A robot system is displayed at the 10th China Smart City and Intelligent Economy Expo in Ningbo, east China’s Zhejiang Province, Sept. 11, 2020. (Xinhua/Huang Zongzhi)

BEIJING, Oct. 28 (Xinhua) — China has been underscoring the key role of sci-tech innovation in its pursuit of high-quality development. However, its sci-tech progress has also raised unnecessary anxiety among some Western politicians, largely out of their own prejudice.

Now the world is closely watching the ongoing plenary session of the 19th Communist Party of China Central Committee, which will map out the country’s 14th Five-Year Plan (2021-2025) for economic and social development. Future sci-tech development strategy in the plan is also a big focus.

Some hardliners in Washington fanfared that China’s sci-tech innovation is “a threat,” an excuse that has been overused in recent years to serve their own political purposes.

Under their manipulative influence, the U.S.

Read More